HCC risk in patients who are HBeAg-positive and have chronic hepatitis B under long-term nucleos(t)ide analogue therapy: New insights from Asia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

HCC risk in patients who are HBeAg-positive and have chronic hepatitis B under long-term nucleos(t)ide analogue therapy: New insights from Asia

Published:2024-02-16 Issue: Volume: Page:
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:

Author:

Papatherodoridis George¹,Lampertico Pietro²³

Affiliation:

1. Department of Gastroenterology, Medical School of National and Kapodistrian University of Athens, General Hospital of Athens “Laiko”, Athens, Greece

2. Division of Gastroenterology and Hepatology, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy

3. Department of Pathophysiology and Transplantation, CRC “A.M. and A. Migliavacca” Center for Liver Disease, University of Milan, Milan, Italy

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference13 articles.

1. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection;J Hepatol,2017

2. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance;Terrault;Hepatology,2018

3. Asian-Pacific clinical practice guidelines on the management of hepatitis B: A 2015 update;Sarin;Hepatol Int,2016

4. Effects of tenofovir disoproxil fumarate in hepatitis B e antigen-positive patients with normal levels of alanine aminotransferase and high levels of hepatitis B virus DNA;Chan;Gastroenterology,2014

5. HBV: Do I treat my immunotolerant patients?;Vlachogiannakos;Liver Int,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP